U.S. Biotech Stock News

Investor focus on Axon Enterprise (AXON) has intensified as expectations build that rising US defense spending could support demand for its AI-powered Fusus and Drone as First Responder platforms across law enforcement and military customers. See our latest analysis for Axon Enterprise. At a latest share price of US$456.60, Axon’s 1 day share price return of 9.99% decline and 7 day return of 10.19% decline sit against a 1 year total shareholder return of 18.33% decline but a 3 year total...

Wondering if Levi Strauss shares at around US$18.43 are giving you genuine value or just the comfort of a familiar brand name? This article focuses squarely on what that current price might imply. The stock has seen a mixed return profile, with a 19.4% decline over the last 30 days and an 11.5% decline year to date, but a 17.8% gain over the past year and 14.5% annualized over three years. These figures can shape how investors think about both potential and risk. Recent coverage has focused...

Merck (NYSE:MRK) agreed to acquire Terns Pharmaceuticals for about $6.7 billion in a deal centered on Terns' chronic myeloid leukemia candidate, TERN-701. The transaction adds an investigational oncology therapy to Merck's pipeline as it prepares for the expected loss of exclusivity on Keytruda in the coming years. Merck enters this deal with shares at $116.37 and a return of 9.3% year to date and 37.2% over the past year, indicating investors have recently priced the stock higher. Over...

Investors may be wondering whether Alibaba Group Holding at around US$125 a share still offers value, or if most of the potential upside has already been reflected in the price. The stock is around US$125.48 after a 7 day return of an 8.1% decline, a 30 day return of an 18.8% decline, a year to date return of a 19.4% decline, while the 1 year return sits at a 3.9% decline and the 3 year return at 34.2%. Recent attention on large Chinese technology names and renewed interest in major e...

Auddia Inc. has unveiled a novel solution to the last-mile delivery challenge with the LT350 micro warehouse network, aiming to transform parking lots into logistics hubs. This innovative platform integrates drones, autonomous EVs, and human couriers through a solar-powered canopy infrastructure, featuring secure lockers, vertical package elevators, and charging facilities. The LT350 system serves not only as a logistics node but also as a digital infrastructure for autonomous vehicles,...

On Holding (NYSE:ONON) has announced a broad leadership reshuffle, as co founders David Allemann and Caspar Coppetti step in as Co CEOs and long serving executive Martin Hoffmann prepares to hand over to incoming CFO Frank Sluis. See our latest analysis for On Holding. The leadership reshuffle comes after a softer patch in the share price, with a 30 day share price return of a 19.89% decline and a 1 year total shareholder return of a 17.47% decline, despite a 3 year total shareholder return...

Boeing contract puts fresh attention on Astronics stock Astronics (ATRO) has been selected by Boeing to supply fuel tank access doors for the 737 MAX program. The contract is tied directly to the company’s design engineering and vertically integrated manufacturing capabilities in Clackamas, Oregon. See our latest analysis for Astronics. Despite the Boeing announcement, Astronics’ share price has recently pulled back, with a 13.28% 1 month share price return and 3.42% 7 day share price return...

Earlier this year, Unum Group expanded its Unum Broker Connect integration with Employee Navigator to add automated billing and eligibility features, aiming to cut manual work and improve accuracy for brokers and employers managing benefits and leave. By automating eligibility data flows into Unum Total Leave, the company is positioning its benefits platform as a more integrated solution for employers grappling with increasingly complex leave management. We’ll now explore how this expanded...

LegalZoom.com (LZ) is back on investors’ radars after Barclays cut its rating to Underweight, flagging a relatively limited addressable market. This move coincides with recent earnings related and broader market pressures. See our latest analysis for LegalZoom.com. The share price has been under steady pressure, with a 1 day share price return of a 4.78% decline, a 30 day share price return of an 8.84% decline, and a 90 day share price return of a 40.32% decline. This leaves the latest close...

DLocal’s latest results, guidance and dividend DLocal (DLO) has drawn fresh attention after reporting quarterly and full year 2025 earnings, issuing operating profit guidance for 2026, and declaring a sizeable cash dividend to shareholders. See our latest analysis for DLocal. DLocal’s recent earnings release, 2026 profit guidance and cash dividend appear to have reset expectations, with a 10.14% 7 day share price return standing out against a weaker 90 day share price return and mixed 3 year...

Why One Stop Systems is attracting fresh attention One Stop Systems (OSS) is back in focus after reporting full year 2025 results that shifted from a prior net loss to net income, alongside guidance calling for 20% to 25% revenue growth in 2026. See our latest analysis for One Stop Systems. Despite the strong 2025 results and new 2026 guidance, the recent 15.4% 7-day share price decline and 7.0% 30-day share price return contrast with a 231.1% 1-year total shareholder return, suggesting...

On 20 March 2026, Central Bancompany, Inc. (NasdaqGS:CBC) was added to a wide range of Russell indices, including the Russell 1000, 2500, 3000, Midcap and their associated value, dynamic and benchmark variants. This broad Russell index inclusion significantly increases CBC’s presence in institutional portfolios, as index-tracking funds may now allocate to the bank, potentially enhancing liquidity and visibility among investors. We’ll now examine how Central Bancompany’s broad Russell index...

Willis Towers Watson (NasdaqGS:WTW) appointed a new global leader for its Work & Rewards business, signaling a refresh in a key advisory unit. The company launched an art insurance facility for collectors and galleries in Asia through a partnership focused on regional specialty coverage. Insurtech firm Thimble adopted WTW’s Radar Live platform to support modernized pricing for commercial lines. WTW shares trade at $293.36, with a value score of 2 and a mixed return profile that includes a...

Wondering if Waste Management at around US$224.94 is priced for perfection or still has room on the upside? This article walks through the key signals that matter for value focused investors. The stock has seen a 4.7% decline over the last 7 days and a 2.3% decline over the last 30 days, while returns sit at 3.0% year to date and 0.6% over the past year, with longer term returns of 52.1% over 3 years and 88.1% over 5 years. Recent price moves sit against a backdrop of ongoing interest in...

PDD Holdings recently confirmed it released its Q4 2025 results before the U.S. market opened on March 25, 2026, followed by an earnings call the same day. The earnings announcement comes as China reiterates its pledge to expand the global “trade pie,” a stance that could influence PDD’s export-focused business model amid ongoing trade tensions. We’ll now examine how expectations around PDD’s upcoming earnings, set against shifting trade policy signals, affect its existing investment...

If you are wondering whether Tenet Healthcare at around US$199.63 is still offering value or has already priced in its story, this breakdown is for you. The stock has recently seen a 5.7% decline over the last 7 days and a 13.2% decline over the last 30 days, while the 1 year return of 52.6% and very large 3 year and 5 year returns keep longer term holders focused. Recent headlines have focused on Tenet Healthcare as investors reassess hospital and healthcare operators, with attention on how...

How JPMorgan Chase (JPM) Has Been Trading Lately JPMorgan Chase (JPM) has seen mixed share performance recently, with a 0.9% gain over the past day and 1.9% over the past week, set against negative returns over the past month and over the past 3 months. See our latest analysis for JPMorgan Chase. The recent 1-day share price return of 0.86% and 7-day gain of 1.92% come after 30-day and 90-day share price returns of 5.92% and 11.17% declines. Longer term total shareholder returns of 18.82%...

The EU is preparing an antitrust decision on Alphabet under the Digital Markets Act, focusing on its conduct as a large online platform. The ruling is expected soon and could shape how Alphabet operates key services across European markets. Regulators are assessing whether Alphabet's current practices comply with new digital competition rules. Alphabet, traded as NasdaqGS:GOOGL, is heading into this regulatory decision with a mixed recent share price record. The stock is at $290.44 after a...

Earlier this week, Elliott Investment Management disclosed a multibillion-dollar stake in Synopsys and said it intends to engage management on boosting software and services revenue and overall profitability. The move introduces an activist shareholder into a company already redefining its role in chip and systems design through the Ansys combination, Arm collaboration, and NVIDIA-aligned AI and hardware-accelerated workflows. Next, we’ll examine how Elliott’s activist push for higher...

Wondering if TransMedics Group at around US$108.92 is priced for its future potential or already reflecting high expectations? This article breaks down what the current share price might be implying about the company. The stock has seen a 12.7% decline over the past week and an 18.9% decline over the last 30 days, even though the 1 year return sits at 53.9% and the 3 year return at 45.8%. Recent coverage has focused on TransMedics Group's position in the medical technology space and what its...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Hamilton Lane stock reacts as Credit Income Fund clears key SEC milestone Hamilton Lane (HLNE) is back in focus after the U.S. Securities and Exchange Commission declared its Hamilton Lane Credit Income Fund effective, opening the door for broader access to middle market senior loan exposure. See our latest analysis for Hamilton Lane. Despite the SEC milestone for its Credit Income Fund, Hamilton Lane’s recent share price momentum has been weak, with a 30-day share price return of 6.98% and a...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

ICON (NasdaqGS:ICLR) has drawn fresh attention after announcing a definitive partnership with Advarra to build a connected, research ready clinical trial site network that aims to simplify operations and widen trial access. See our latest analysis for ICON. Despite the Advarra agreement and recent conference appearances, ICON’s recent share price return has been mixed, with modest gains over the past month but a much weaker 90 day share price return of 44.9% and a 1 year total shareholder...